Pharmacology Examination Paper
2026/2027 | 110 Multiple Choice Questions
with Detailed Explanations for Medical,
Pharmacy & Nursing Students
Description:
Master pharmacology with this comprehensive 2026/2027 examination paper featuring 110
high-yield MCQs on adrenergic receptors, cardiovascular drugs, antimicrobials, CNS
agents, and clinical toxicology. Each question includes detailed explanations aligned with
current board exam standards. Perfect for USMLE, NAPLEX, COMLEX, MBBS, and
NEET-PG preparation.
Download the complete 2026/2027 pharmacology exam paper now and ace your boards!
, Pharmacology Exam 2026/2027: 110 MCQs with Answers
Adrenergic Receptor Functions
Question 1
Which of the following correctly describes the major functions of the α1 receptor?
A. Decrease sympathetic outflow, decrease insulin release, increase platelet aggregation
B. Increase heart rate, increase contractility, increase renin release
C. Increase vascular smooth muscle contraction, increase pupillary dilator muscle
contraction, increase intestinal and bladder sphincter contraction
D. Vasodilation, bronchodilation, increase insulin release, decrease uterine tone
Answer: C
Explanation: Alpha-1 adrenergic receptors mediate smooth muscle contraction in various
tissues. Activation causes vasoconstriction in blood vessels, mydriasis via contraction of the
pupillary dilator muscle, and increased tone of gastrointestinal and urinary sphincters. These
effects are clinically relevant in managing hypotension, during ophthalmic examinations, and
in conditions requiring increased sphincter tone.
Question 2
A patient experiences bradycardia and hypotension following administration of a medication.
Which receptor type, when activated, would most directly address these symptoms by
increasing both heart rate and contractility?
A. α1 receptor
B. β1 receptor
C. β2 receptor
D. M2 receptor
Answer: B
Explanation: Beta-1 adrenergic receptors are predominantly located in the heart and
juxtaglomerular cells of the kidney. Activation increases heart rate (positive chronotropy),
myocardial contractility (positive inotropy), and renin release. This makes β1 agonists
valuable in managing cardiogenic shock and heart failure with reduced ejection fraction.
,Question 3
A patient with asthma is given a medication that causes bronchodilation, increased heart rate,
and mild tremors. Which receptor is most likely responsible for the bronchodilation?
A. β1 receptor
B. β2 receptor
C. M3 receptor
D. H1 receptor
Answer: B
Explanation: Beta-2 adrenergic receptors are located on bronchial smooth muscle, where
activation causes relaxation and bronchodilation. However, non-selective β2 agonists may
also stimulate cardiac β1 receptors, leading to tachycardia. Selective β2 agonists such as
albuterol minimize cardiac effects while providing effective bronchodilation for asthma
management.
Question 4
Activation of the M3 receptor would produce which of the following effects?
A. Decreased heart rate and reduced atrial contractility
B. Increased exocrine gland secretions, increased gut peristalsis, and pupillary sphincter
contraction
C. Decreased sympathetic outflow and decreased insulin release
D. Relaxation of renal vascular smooth muscle
Answer: B
Explanation: M3 muscarinic receptors are widely distributed on exocrine glands (lacrimal,
salivary, gastric), smooth muscle of the gastrointestinal tract, urinary bladder, and the
pupillary sphincter muscle. Activation stimulates glandular secretion, increases peristalsis,
contracts the bladder detrusor, and causes miosis. These effects are the basis for using
cholinergic agonists in conditions like xerostomia or urinary retention.
, Question 5
A patient develops hypertension, hyperglycemia, and weight gain after long-term use of a
medication. Which receptor type, when chronically activated, is most associated with these
metabolic effects?
A. α2 receptor
B. β2 receptor
C. Glucocorticoid receptor
D. D1 receptor
Answer: C
Explanation: While the question tests differentiation from adrenergic receptors, chronic
glucocorticoid receptor activation produces classic Cushingoid features including
hypertension, hyperglycemia, central obesity, and muscle wasting. This distinguishes
hormonal receptor pharmacology from autonomic receptor pharmacology, an important
concept in understanding adverse effect profiles.
Autonomic Pharmacology
Question 6
A 72-year-old man with Alzheimer disease is started on donepezil. The mechanism of action
of this medication is:
A. Direct muscarinic receptor agonist
B. Nicotinic receptor antagonist
C. Acetylcholinesterase inhibitor
D. NMDA receptor antagonist
Answer: C
Explanation: Donepezil is a centrally acting acetylcholinesterase inhibitor that increases
acetylcholine levels in the synaptic cleft by preventing its hydrolysis. This compensatory
increase in cholinergic neurotransmission is modestly effective in slowing cognitive decline
in Alzheimer disease. Unlike physostigmine, donepezil has better oral bioavailability and
longer duration of action, making suitable for once-daily dosing.
2026/2027 | 110 Multiple Choice Questions
with Detailed Explanations for Medical,
Pharmacy & Nursing Students
Description:
Master pharmacology with this comprehensive 2026/2027 examination paper featuring 110
high-yield MCQs on adrenergic receptors, cardiovascular drugs, antimicrobials, CNS
agents, and clinical toxicology. Each question includes detailed explanations aligned with
current board exam standards. Perfect for USMLE, NAPLEX, COMLEX, MBBS, and
NEET-PG preparation.
Download the complete 2026/2027 pharmacology exam paper now and ace your boards!
, Pharmacology Exam 2026/2027: 110 MCQs with Answers
Adrenergic Receptor Functions
Question 1
Which of the following correctly describes the major functions of the α1 receptor?
A. Decrease sympathetic outflow, decrease insulin release, increase platelet aggregation
B. Increase heart rate, increase contractility, increase renin release
C. Increase vascular smooth muscle contraction, increase pupillary dilator muscle
contraction, increase intestinal and bladder sphincter contraction
D. Vasodilation, bronchodilation, increase insulin release, decrease uterine tone
Answer: C
Explanation: Alpha-1 adrenergic receptors mediate smooth muscle contraction in various
tissues. Activation causes vasoconstriction in blood vessels, mydriasis via contraction of the
pupillary dilator muscle, and increased tone of gastrointestinal and urinary sphincters. These
effects are clinically relevant in managing hypotension, during ophthalmic examinations, and
in conditions requiring increased sphincter tone.
Question 2
A patient experiences bradycardia and hypotension following administration of a medication.
Which receptor type, when activated, would most directly address these symptoms by
increasing both heart rate and contractility?
A. α1 receptor
B. β1 receptor
C. β2 receptor
D. M2 receptor
Answer: B
Explanation: Beta-1 adrenergic receptors are predominantly located in the heart and
juxtaglomerular cells of the kidney. Activation increases heart rate (positive chronotropy),
myocardial contractility (positive inotropy), and renin release. This makes β1 agonists
valuable in managing cardiogenic shock and heart failure with reduced ejection fraction.
,Question 3
A patient with asthma is given a medication that causes bronchodilation, increased heart rate,
and mild tremors. Which receptor is most likely responsible for the bronchodilation?
A. β1 receptor
B. β2 receptor
C. M3 receptor
D. H1 receptor
Answer: B
Explanation: Beta-2 adrenergic receptors are located on bronchial smooth muscle, where
activation causes relaxation and bronchodilation. However, non-selective β2 agonists may
also stimulate cardiac β1 receptors, leading to tachycardia. Selective β2 agonists such as
albuterol minimize cardiac effects while providing effective bronchodilation for asthma
management.
Question 4
Activation of the M3 receptor would produce which of the following effects?
A. Decreased heart rate and reduced atrial contractility
B. Increased exocrine gland secretions, increased gut peristalsis, and pupillary sphincter
contraction
C. Decreased sympathetic outflow and decreased insulin release
D. Relaxation of renal vascular smooth muscle
Answer: B
Explanation: M3 muscarinic receptors are widely distributed on exocrine glands (lacrimal,
salivary, gastric), smooth muscle of the gastrointestinal tract, urinary bladder, and the
pupillary sphincter muscle. Activation stimulates glandular secretion, increases peristalsis,
contracts the bladder detrusor, and causes miosis. These effects are the basis for using
cholinergic agonists in conditions like xerostomia or urinary retention.
, Question 5
A patient develops hypertension, hyperglycemia, and weight gain after long-term use of a
medication. Which receptor type, when chronically activated, is most associated with these
metabolic effects?
A. α2 receptor
B. β2 receptor
C. Glucocorticoid receptor
D. D1 receptor
Answer: C
Explanation: While the question tests differentiation from adrenergic receptors, chronic
glucocorticoid receptor activation produces classic Cushingoid features including
hypertension, hyperglycemia, central obesity, and muscle wasting. This distinguishes
hormonal receptor pharmacology from autonomic receptor pharmacology, an important
concept in understanding adverse effect profiles.
Autonomic Pharmacology
Question 6
A 72-year-old man with Alzheimer disease is started on donepezil. The mechanism of action
of this medication is:
A. Direct muscarinic receptor agonist
B. Nicotinic receptor antagonist
C. Acetylcholinesterase inhibitor
D. NMDA receptor antagonist
Answer: C
Explanation: Donepezil is a centrally acting acetylcholinesterase inhibitor that increases
acetylcholine levels in the synaptic cleft by preventing its hydrolysis. This compensatory
increase in cholinergic neurotransmission is modestly effective in slowing cognitive decline
in Alzheimer disease. Unlike physostigmine, donepezil has better oral bioavailability and
longer duration of action, making suitable for once-daily dosing.
